Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.

scientific article published in December 2014

Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSPROCEED.2014.09.096
P698PubMed publication ID25498054
P5875ResearchGate publication ID269727965

P2093author name stringS Shin
M H Park
H Park
E Y Song
K U Park
J W In
E Y Rho
P2860cites workAnti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative PatientsQ82213207
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptorQ33848380
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implicationsQ34315026
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.Q36248631
Kidney in hypertension: guyton reduxQ37106906
Humoral responses directed against non-human leukocyte antigens in solid-organ transplantationQ37306433
Banff 07 classification of renal allograft pathology: updates and future directionsQ40121163
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejectionQ45259438
Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.Q46727061
Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesisQ48577521
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.Q50674616
Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry.Q52668051
Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantationQ56898402
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertensionQ71662795
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertensionQ74126541
Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cellsQ74317809
Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allograftsQ74550738
The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejectionQ79882539
Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunctionQ80379527
Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodiesQ81448662
Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantationQ81680338
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
P304page(s)3371-3374
P577publication date2014-12-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleAnti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.
P478volume46

Reverse relations

cites work (P2860)
Q46409439Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation
Q100408260Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review
Q47571875C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies
Q64939685Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies.
Q37642331Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.
Q48160896Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Q39217968Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection
Q89029587Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients
Q42233729The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes.
Q53186858The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation.
Q38877375The importance of non-HLA antibodies in transplantation